395 related articles for article (PubMed ID: 22787398)
41. Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route.
Gabal YM; Kamel AO; Sammour OA; Elshafeey AH
Int J Pharm; 2014 Oct; 473(1-2):442-57. PubMed ID: 25062866
[TBL] [Abstract][Full Text] [Related]
42. A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity.
Jian Y; Zhao M; Cao J; Fan T; Bu W; Yang Y; Li W; Zhang W; Qiao Y; Wang J; Wen A
Drug Des Devel Ther; 2020; 14():2355-2370. PubMed ID: 32606603
[TBL] [Abstract][Full Text] [Related]
43. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of lipid nanoparticles for topical delivery of protocatechuic acid and ethyl protocatechuate as a new photoprotection strategy.
Daré RG; Costa A; Nakamura CV; Truiti MCT; Ximenes VF; Lautenschlager SOS; Sarmento B
Int J Pharm; 2020 May; 582():119336. PubMed ID: 32304728
[TBL] [Abstract][Full Text] [Related]
45. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles.
Elnaggar YS; El-Massik MA; Abdallah OY
Int J Nanomedicine; 2011; 6():3195-205. PubMed ID: 22238508
[TBL] [Abstract][Full Text] [Related]
46. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery.
Lin YK; Huang ZR; Zhuo RZ; Fang JY
Int J Nanomedicine; 2010 Mar; 5():117-28. PubMed ID: 20309398
[TBL] [Abstract][Full Text] [Related]
47. Cutaneous penetration of soft nanoparticles via photodamaged skin: Lipid-based and polymer-based nanocarriers for drug delivery.
Hung CF; Chen WY; Hsu CY; Aljuffali IA; Shih HC; Fang JY
Eur J Pharm Biopharm; 2015 Aug; 94():94-105. PubMed ID: 25986584
[TBL] [Abstract][Full Text] [Related]
48. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
Abd-Elhakeem E; El-Nabarawi M; Shamma R
Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
[TBL] [Abstract][Full Text] [Related]
49. Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy.
Chen Z; Lai X; Song S; Zhu X; Zhu J
Drug Deliv; 2016 May; 23(4):1369-73. PubMed ID: 26017099
[TBL] [Abstract][Full Text] [Related]
50. Metronidazole-loaded nanostructured lipid carriers to improve skin deposition and retention in the treatment of rosacea.
Shinde UA; Parmar SJ; Easwaran S
Drug Dev Ind Pharm; 2019 Jul; 45(7):1039-1051. PubMed ID: 30727789
[TBL] [Abstract][Full Text] [Related]
51. Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy.
Li S; Chen L; Wang G; Xu L; Hou S; Chen Z; Xu X; Wang X; Liu F; Du YZ
J Nanobiotechnology; 2018 Dec; 16(1):105. PubMed ID: 30594254
[TBL] [Abstract][Full Text] [Related]
52. Formulation design, preparation, and in vitro and in vivo characterizations of β-Elemene-loaded nanostructured lipid carriers.
Shi F; Yang G; Ren J; Guo T; Du Y; Feng N
Int J Nanomedicine; 2013; 8():2533-41. PubMed ID: 23901271
[TBL] [Abstract][Full Text] [Related]
53. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis.
Gu Y; Tang X; Yang M; Yang D; Liu J
Int J Pharm; 2019 Jan; 554():235-244. PubMed ID: 30423415
[TBL] [Abstract][Full Text] [Related]
54. Ibrutinib topical delivery for melanoma treatment: The effect of nanostructured lipid carriers' composition on the controlled drug skin deposition.
Albuquerque LFF; Lins FV; Bispo ECI; Borges EN; Silva MT; Gratieri T; Cunha-Filho M; Alonso A; Carvalho JL; Saldanha-Araujo F; Gelfuso GM
Colloids Surf B Biointerfaces; 2024 May; 237():113875. PubMed ID: 38547795
[TBL] [Abstract][Full Text] [Related]
55. Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines.
Baishya R; Nayak DK; Kumar D; Sinha S; Gupta A; Ganguly S; Debnath MC
Pharm Res; 2016 Nov; 33(11):2691-703. PubMed ID: 27431865
[TBL] [Abstract][Full Text] [Related]
56. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides.
Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y
Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758
[TBL] [Abstract][Full Text] [Related]
57. Nanostructured lipid carriers for the topical delivery of tretinoin.
Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
[TBL] [Abstract][Full Text] [Related]
58. Podophyllotoxin-Loaded Nanostructured Lipid Carriers for Skin Targeting: In Vitro and In Vivo Studies.
Zhao J; Piao X; Shi X; Si A; Zhang Y; Feng N
Molecules; 2016 Nov; 21(11):. PubMed ID: 27869698
[TBL] [Abstract][Full Text] [Related]
59. Enhanced skin penetration of lidocaine through encapsulation into nanoethosomes and nanostructured lipid carriers: a comparative study.
Babaei S; Ghanbarzadeh S; Adib ZM; Kouhsoltani M; Davaran S; Hamishehkar H
Pharmazie; 2016 May; 71(5):247-51. PubMed ID: 27348967
[TBL] [Abstract][Full Text] [Related]
60. Cyproterone acetate-loaded nanostructured lipid carriers: effect of particle size on skin penetration and follicular targeting.
Ghasemiyeh P; Azadi A; Daneshamouz S; Heidari R; Azarpira N; Mohammadi-Samani S
Pharm Dev Technol; 2019 Sep; 24(7):812-823. PubMed ID: 30889371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
